Evidence for a protective role of CD8+ T cells against SARS-CoV-2 is provided by preclinical models where infection drives antibody and T cell responses, and CD8+ cell depletion diminishes protection upon rechallenge (5). The gene discussed is CD8A; the disease is infection.